Study of Nivolumab in Patients With Advanced Refractory Biliary Tract Cancers
H. Lee Moffitt Cancer Center and Research Institute
H. Lee Moffitt Cancer Center and Research Institute
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Boston Scientific Corporation
Boston Scientific Corporation
Pfizer
National Cancer Center Hospital East
Beijing Tsinghua Chang Gung Hospital
Centre Paul Strauss
Brigham and Women's Hospital
IDRx Inc. - A GSK Company
Centre Francois Baclesse
Dartmouth-Hitchcock Medical Center
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Lund University Hospital
Pfizer
University of Pittsburgh
Hoffmann-La Roche
University of Alabama at Birmingham
Thomas Jefferson University
Thomas Jefferson University
Revolution Medicines, Inc.
Celgene
Boston Scientific Corporation
Imperial College London
University of Alberta
Imunon
University of Aarhus
NanOlogy, LLC
Theseus Pharmaceuticals
Duke University
University Medical Center Groningen
OncoSil Medical Limited
Kyowa Kirin Co., Ltd.
Taipei Veterans General Hospital, Taiwan
University Hospital, Antwerp
Fudan University
Catalysis SL
Catalysis SL
Anova Enterprises, Inc
Qure Healthcare, LLC
Sumitomo Pharma America, Inc.
Sumitomo Pharma America, Inc.
The First Affiliated Hospital with Nanjing Medical University
Xijing Hospital
The Second Affiliated Hospital of Fujian Medical University
Celgene
Advanced Endoscopy Research, Robert Wood Johnson Medical School Rutgers University
Catalysis SL
Sociedad Española de Medicina Nuclear e Imagen Molecular